{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:37:34Z","timestamp":1762324654601,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K09358A","JP17K09420"],"award-info":[{"award-number":["JP16K09358A","JP17K09420"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While direct-acting antivirals (DAAs) for hepatitis C virus (HCV) have dramatically progressed, patients still suffer from treatment failures. For the radical eradication of HCV, a deeper understanding of multiple resistance-associated substitutions (RASs) at the single-clone level is essential. To understand HCV <jats:italic>quasispecies<\/jats:italic> and their dynamics during DAA treatment, we applied single-molecule real-time (SMRT) deep sequencing on sera from 12 patients with genotype-1b HCV infections with DAA treatment failures, both pre- and post-treatment. We identified &gt;3.2 kbp sequences between NS3 and NS5A genes of 187,539 clones in total, classifying into haplotype codes based on the linkage of seven RAS loci. The number of haplotype codes during the treatment, per sample, significantly decreased from 14.67\u2009\u00b1\u20099.12 to 6.58\u2009\u00b1\u20097.1, while the number of nonsynonymous codons on the seven RAS loci, per clone, significantly increased from 1.50\u2009\u00b1\u20090.92 to 3.64\u2009\u00b1\u20090.75. In five cases, the minority multi-drug resistant haplotypes at pre-treatment were identical to the major haplotypes at relapse. Moreover, various structural variations (SVs) were detected and their dynamics analysed. These results suggest that SMRT deep sequencing is useful for detecting minority haplotypes and SVs, and to evaluate the dynamics of viral genomes at the single-clone level.<\/jats:p>","DOI":"10.1038\/s41598-020-59397-2","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T11:03:14Z","timestamp":1581678194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Single-molecular real-time deep sequencing reveals the dynamics of multi-drug resistant haplotypes and structural variations in the hepatitis C virus genome"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5465-534X","authenticated-orcid":false,"given":"Taiki","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Arasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyasu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Mashimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Hozan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Ohtsuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Seno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"59397_CR1","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/hep.27113","volume":"59","author":"H Kumada","year":"2014","unstructured":"Kumada, H. et al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology 59, 2083\u20132091, https:\/\/doi.org\/10.1002\/hep.27113 (2014).","journal-title":"Hepatology"},{"key":"59397_CR2","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S0140-6736(14)61059-X","volume":"384","author":"M Manns","year":"2014","unstructured":"Manns, M. et al. All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study. Lancet 384, 1597\u20131605, https:\/\/doi.org\/10.1016\/S0140-6736(14)61059-X (2014).","journal-title":"Lancet"},{"key":"59397_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","volume":"149","author":"M Charlton","year":"2015","unstructured":"Charlton, M. et al. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease. Gastroenterology 149, 649\u2013659, https:\/\/doi.org\/10.1053\/j.gastro.2015.05.010 (2015).","journal-title":"Gastroenterology"},{"key":"59397_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMoa1702417","volume":"378","author":"S Zeuzem","year":"2018","unstructured":"Zeuzem, S. et al. Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection. N. Engl. J. Med. 378, 354\u2013369, https:\/\/doi.org\/10.1056\/NEJMoa1702417 (2018).","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"59397_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/v10100531","volume":"10","author":"C. Hayes","year":"2018","unstructured":"Hayes, C. N., Zhang, P., Zhang, Y. & Chayama, K. Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection. Viruses 10, https:\/\/doi.org\/10.3390\/v10100531 (2018).","journal-title":"Viruses"},{"key":"59397_CR6","doi-asserted-by":"publisher","first-page":"831","DOI":"10.4254\/wjh.v7.i6.831","volume":"7","author":"N Echeverr\u00eda","year":"2015","unstructured":"Echeverr\u00eda, N., Moratorio, G., Cristina, J. & Moreno, P. Hepatitis C virus genetic variability and evolution. World J. Hepatol. 7, 831\u2013845, https:\/\/doi.org\/10.4254\/wjh.v7.i6.831 (2015).","journal-title":"World J. Hepatol."},{"issue":"1","key":"59397_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms19010023","volume":"19","author":"Kyoko Tsukiyama-Kohara","year":"2017","unstructured":"Tsukiyama-Kohara, K. & Kohara, M. Hepatitis C Virus: Viral Quasispecies and Genotypes. Int. J. Mol. Sci. 19, https:\/\/doi.org\/10.3390\/ijms19010023 (2017).","journal-title":"International Journal of Molecular Sciences"},{"key":"59397_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jcv.2012.12.020","volume":"57","author":"D Hernandez","year":"2013","unstructured":"Hernandez, D., Zhou, N., Ueland, J., Monikowski, A. & McPhee, F. Natural prevalence of NS5A polymorphisms in subjects infected with hepatitis C virus genotype 3 and their effects on the antiviral activity of NS5A inhibitors. J. Clin. Virol. 57, 13\u201318, https:\/\/doi.org\/10.1016\/j.jcv.2012.12.020 (2013).","journal-title":"J. Clin. Virol."},{"key":"59397_CR9","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1128\/JVI.00253-11","volume":"85","author":"RA Fridell","year":"2011","unstructured":"Fridell, R. A. et al. Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052. J. Virol. 85, 7312\u20137320, https:\/\/doi.org\/10.1128\/JVI.00253-11 (2011).","journal-title":"J. Virol."},{"key":"59397_CR10","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1021\/jm401398x","volume":"57","author":"DA DeGoey","year":"2014","unstructured":"DeGoey, D. A. et al. Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A. J. Med. Chem. 57, 2047\u20132057, https:\/\/doi.org\/10.1021\/jm401398x (2014).","journal-title":"J. Med. Chem."},{"key":"59397_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1128\/AAC.04226-14","volume":"59","author":"P Krishnan","year":"2015","unstructured":"Krishnan, P. et al. In vitro and in vivo antiviral activity and resistance profile of ombitasvir, an inhibitor of hepatitis C virus NS5A. Antimicrob. Agents Chemother. 59, 979\u2013987, https:\/\/doi.org\/10.1128\/AAC.04226-14 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59397_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00535-018-1520-9","volume":"54","author":"M Osawa","year":"2019","unstructured":"Osawa, M. et al. Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures. J. Gastroenterol. 54, 291\u2013296, https:\/\/doi.org\/10.1007\/s00535-018-1520-9 (2019).","journal-title":"J. Gastroenterol."},{"key":"59397_CR13","doi-asserted-by":"publisher","unstructured":"Krishnan, P. et al. Integrated Resistance Analysis of CERTAIN-1 and CERTAIN-2 Studies in Hepatitis C Virus-Infected Patients Receiving Glecaprevir and Pibrentasvir in Japan. Antimicrob. Agents Chemother. 62, https:\/\/doi.org\/10.1128\/AAC.02217-17 (2018).","DOI":"10.1128\/AAC.02217-17"},{"key":"59397_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s00535-017-1396-0","volume":"53","author":"H Kumada","year":"2018","unstructured":"Kumada, H. et al. Efficacy and safety of glecaprevir\/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection. J. Gastroenterol. 53, 566\u2013575, https:\/\/doi.org\/10.1007\/s00535-017-1396-0 (2018).","journal-title":"J. Gastroenterol."},{"key":"59397_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00535-018-01543-9","volume":"54","author":"H Uemura","year":"2019","unstructured":"Uemura, H. et al. NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir. J. Gastroenterol. 54, 459\u2013470, https:\/\/doi.org\/10.1007\/s00535-018-01543-9 (2019).","journal-title":"J. Gastroenterol."},{"key":"59397_CR16","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1128\/AAC.02494-12","volume":"57","author":"C Wang","year":"2013","unstructured":"Wang, C. et al. Persistence of resistant variants in hepatitis C virus-infected patients treated with the NS5A replication complex inhibitor daclatasvir. Antimicrob. Agents Chemother. 57, 2054\u20132065, https:\/\/doi.org\/10.1128\/AAC.02494-12 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59397_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3851\/IMP3123","volume":"22","author":"Y Gozlan","year":"2017","unstructured":"Gozlan, Y. et al. HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patients. Antivir. Ther. 22, 431\u2013441, https:\/\/doi.org\/10.3851\/IMP3123 (2017).","journal-title":"Antivir. Ther."},{"issue":"11","key":"59397_CR18","doi-asserted-by":"publisher","first-page":"e13109","DOI":"10.1111\/ctr.13109","volume":"31","author":"Toru Ikegami","year":"2017","unstructured":"Ikegami, T. et al. Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation: A Japanese multicenter experience. Clin. Transplant. 31, https:\/\/doi.org\/10.1111\/ctr.13109 (2017).","journal-title":"Clinical Transplantation"},{"key":"59397_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrg.2016.49","volume":"17","author":"S Goodwin","year":"2016","unstructured":"Goodwin, S., McPherson, J. D. & McCombie, W. R. Coming of age: ten years of next-generation sequencing technologies. Nat. Rev. Genet. 17, 333\u2013351, https:\/\/doi.org\/10.1038\/nrg.2016.49 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"59397_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcv.2014.06.013","volume":"61","author":"ME Qui\u00f1ones-Mateu","year":"2014","unstructured":"Qui\u00f1ones-Mateu, M. E., Avila, S., Reyes-Teran, G. & Martinez, M. A. Deep sequencing: becoming a critical tool in clinical virology. J. Clin. Virol. 61, 9\u201319, https:\/\/doi.org\/10.1016\/j.jcv.2014.06.013 (2014).","journal-title":"J. Clin. Virol."},{"key":"59397_CR21","doi-asserted-by":"publisher","first-page":"e49602","DOI":"10.1371\/journal.pone.0049602","volume":"7","author":"J Archer","year":"2012","unstructured":"Archer, J. et al. Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism. PLoS One 7, e49602, https:\/\/doi.org\/10.1371\/journal.pone.0049602 (2012).","journal-title":"PLoS One"},{"key":"59397_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1126\/science.1162986","volume":"323","author":"J Eid","year":"2009","unstructured":"Eid, J. et al. Real-time DNA sequencing from single polymerase molecules. Science 323, 133\u2013138, https:\/\/doi.org\/10.1126\/science.1162986 (2009).","journal-title":"Science"},{"key":"59397_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.12688\/f1000research.7201.1","volume":"4","author":"CLC Ip","year":"2015","unstructured":"Ip, C. L. C. et al. MinION Analysis and Reference Consortium: Phase 1 data release and analysis. F1000Res 4, 1075, https:\/\/doi.org\/10.12688\/f1000research.7201.1 (2015).","journal-title":"F1000Res"},{"key":"59397_CR24","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3748\/wjg.v25.i32.4661","volume":"25","author":"H Takeda","year":"2019","unstructured":"Takeda, H., Yamashita, T., Ueda, Y. & Sekine, A. Exploring the hepatitis C virus genome using single molecule real-time sequencing. World J. Gastroenterol. 25, 4661\u20134672, https:\/\/doi.org\/10.3748\/wjg.v25.i32.4661 (2019).","journal-title":"World J. Gastroenterol."},{"key":"59397_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/srep45605","volume":"7","author":"H Takeda","year":"2017","unstructured":"Takeda, H. et al. Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencing. Sci. Rep. 7, 45605, https:\/\/doi.org\/10.1038\/srep45605 (2017).","journal-title":"Sci. Rep."},{"key":"59397_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403\u2013410, https:\/\/doi.org\/10.1016\/S0022-2836(05)80360-2 (1990).","journal-title":"J. Mol. Biol."},{"key":"59397_CR27","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1128\/JCM.00676-13","volume":"51","author":"S Ohtsuru","year":"2013","unstructured":"Ohtsuru, S. et al. Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis. J. Clin. Microbiol. 51, 3645\u20133652, https:\/\/doi.org\/10.1128\/JCM.00676-13 (2013).","journal-title":"J. Clin. Microbiol."},{"key":"59397_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hep.27361","volume":"61","author":"C Hedskog","year":"2015","unstructured":"Hedskog, C. et al. Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir\/ribavirin. Hepatology 61, 471\u2013480, https:\/\/doi.org\/10.1002\/hep.27361 (2015).","journal-title":"Hepatology"},{"key":"59397_CR29","unstructured":"Pacific Biosciences. Procedure & Checklist \u2013 Preparing Multiplexed Microbial SMRTbell Libraries for the PacBio Sequel System, https:\/\/www.pacb.com\/wp-content\/uploads\/Procedure-Checklist-Preparing-Multiplexed-Microbial-SMRTbell-Libraries-for-the-PacBio-Sequel-System.pdf (2018)."},{"key":"59397_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-238","volume":"13","author":"MJ Chaisson","year":"2012","unstructured":"Chaisson, M. J. & Tesler, G. Mapping single molecule sequencing reads using basic local alignment with successive refinement (BLASR): application and theory. BMC Bioinformatics 13, 238, https:\/\/doi.org\/10.1186\/1471-2105-13-238 (2012).","journal-title":"BMC Bioinformatics"},{"key":"59397_CR31","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303, https:\/\/doi.org\/10.1101\/gr.107524.110 (2010).","journal-title":"Genome Res."},{"key":"59397_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41592-018-0001-7","volume":"15","author":"FJ Sedlazeck","year":"2018","unstructured":"Sedlazeck, F. J. et al. Accurate detection of complex structural variations using single-molecule sequencing. Nat. Methods 15, 461\u2013468, https:\/\/doi.org\/10.1038\/s41592-018-0001-7 (2018).","journal-title":"Nat. Methods"},{"key":"59397_CR33","doi-asserted-by":"publisher","first-page":"e1005944","DOI":"10.1371\/journal.pcbi.1005944","volume":"14","author":"G Mar\u00e7ais","year":"2018","unstructured":"Mar\u00e7ais, G. et al. MUMmer4: A fast and versatile genome alignment system. PLoS Comput. Biol. 14, e1005944, https:\/\/doi.org\/10.1371\/journal.pcbi.1005944 (2018).","journal-title":"PLoS Comput. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59397-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59397-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59397-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:00:33Z","timestamp":1670310033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59397-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59397"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59397-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2651"}}